Treatment of Catheter-Related Arterial Thrombosis in Children: A 15-Year Single- Center Experience

J Pediatr. 2021 Dec:239:182-186. doi: 10.1016/j.jpeds.2021.08.035. Epub 2021 Aug 24.

Abstract

Objective: To investigate treatment modalities for children with extremity indwelling catheter (EIC)- or cardiac catheter-related arterial thrombosis.

Study design: The treatment of consecutive cases of catheter-related arterial thrombosis (CAT) at our institution between 2002 and 2017 was analyzed retrospectively.

Results: A total of 242 CATs developed in 224 children. Of these, 125 (52%) were EIC-related and 117 (48%) were cardiac catheter-related. Treatment included heparin alone in 60 cases (25%), acetylsalicyclic acid (ASA) alone in 6 cases (2%), heparin followed by ASA in 171 cases (71%), heparin followed by vitamin K antagonist (VKA) in 4 cases (1.5%), and VKA alone in 1 case (0.5%). Complete resolution of CAT was observed in 173 cases (71.5%), partial resolution in 13 cases (5.4%), and no resolution in 56 cases (23.1%). No statistical significance in the resolution rate was observed between treatment groups (P = .23). In 66% of cases, complete resolution occurred at a median of 18 days (range, 4-44 days) with heparin alone. A switch from heparin to ASA in children with partial or no resolution of CAT did not increase the resolution rate at follow-up.

Conclusions: Heparin is an efficient treatment modality for CAT in pediatric patients. Long-term, subsequent treatment with ASA does not increase the resolution rate.

MeSH terms

  • Adolescent
  • Anticoagulants / therapeutic use*
  • Aspirin / therapeutic use
  • Cardiac Catheterization / adverse effects*
  • Catheters, Indwelling / adverse effects*
  • Child
  • Child, Preschool
  • Drug Administration Schedule
  • Drug Therapy, Combination
  • Female
  • Femoral Artery*
  • Fibrinolytic Agents / therapeutic use*
  • Follow-Up Studies
  • Heparin / therapeutic use
  • Humans
  • Iliac Artery*
  • Infant
  • Infant, Newborn
  • Male
  • Retrospective Studies
  • Thrombosis / drug therapy*
  • Thrombosis / etiology
  • Treatment Outcome
  • Vitamin K / antagonists & inhibitors

Substances

  • Anticoagulants
  • Fibrinolytic Agents
  • Vitamin K
  • Heparin
  • Aspirin